相关实验视频

Updated: May 1, 2026

Murine Prostate Micro-dissection and Surgical Castration

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

整个蛋白质组的门德尔随机化确定了前列腺癌发展中的因果性血蛋白

Jian Wu¹, Zitong Yang^1,2, Jiafeng Ding^1,3

¹Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang, China.

|February 25, 2025

概括

这项研究使用孟德尔随机化确定了与前列腺癌风险相关的9种血蛋白. SMAD2和CREB3L4显示出显著的因果关系,表明它们在前列腺癌的发展和治疗中的潜在作用.

科学领域:

遗传学遗传学是一个
在瘤学瘤学.
生物化学生物化学

背景情况:

前列腺癌的原因尚未完全理解.
血蛋白水平与前列腺癌风险之间的关联尚不清楚.

研究的目的:

研究血蛋白水平与前列腺癌风险之间的因果关系.
确定可能影响前列腺癌发展的特定血蛋白.

主要方法:

门德尔随机化分析使用cis-protein定量特征位点 (cis-pQTL) 变体进行.
分析了来自PRACTICAL联盟的数据,结果在FinnGen联盟中复制.
评估了血蛋白和循环基因表达对前列腺癌风险的因果作用.

主要成果:

四种血蛋白 (CREB3L4,HDGF,SERPINA3,GNPNAT1) 与前列腺癌风险增加正相关.
五种血蛋白 (TNFRSF6B,GSK3A,EIF4B,CLIC1,SMAD2) 与降低前列腺癌风险有关.
在复制和元分析中证实了CREB3L4,HDGF,SERPINA3,TNFRSF6B,EIF4B和SMAD2的因果作用.

结论:

血中的SMAD2和CREB3L4水平与前列腺癌风险有显著的关联.
这些蛋白质可能在前列腺癌病因学中发挥关键作用.
对SMAD2和CREB3L4的进一步研究可以为前列腺癌预防和治疗策略提供信息.

关键词:

这就是CREB3L4L4的意思.门德尔的随机化血蛋白质组中的蛋白质组.前列腺癌是什么意思前列腺癌是什么意思这就是SMAD2的原因.

更多相关视频

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...